Cargando…

Use and impact of social prescribing: a mixed-methods feasibility study protocol

INTRODUCTION: Social prescribing aims to address social determinants of health, which account for 80%–90% of health outcomes, but the evidence base behind it is limited due to a lack of data linkingsocial prescribing activity and outcomes. METHODS AND ANALYSIS: The objective of the quantitative comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Jani, Anant, Liyanage, Harshana, Hoang, Uy, Moore, Lucy, Ferreira, Filipa, Yonova, Ivelina, Tzortziou Brown, Victoria, de Lusignan, Simon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511614/
https://www.ncbi.nlm.nih.gov/pubmed/32948564
http://dx.doi.org/10.1136/bmjopen-2020-037681
_version_ 1783585991222624256
author Jani, Anant
Liyanage, Harshana
Hoang, Uy
Moore, Lucy
Ferreira, Filipa
Yonova, Ivelina
Tzortziou Brown, Victoria
de Lusignan, Simon
author_facet Jani, Anant
Liyanage, Harshana
Hoang, Uy
Moore, Lucy
Ferreira, Filipa
Yonova, Ivelina
Tzortziou Brown, Victoria
de Lusignan, Simon
author_sort Jani, Anant
collection PubMed
description INTRODUCTION: Social prescribing aims to address social determinants of health, which account for 80%–90% of health outcomes, but the evidence base behind it is limited due to a lack of data linkingsocial prescribing activity and outcomes. METHODS AND ANALYSIS: The objective of the quantitative component of this feasibility studyisto identify the characteristics of individuals who receive social prescriptions and describe the use and estimate the impact of social prescribing; the latter will be done on a homeless subgroup. We will use the Oxford Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) primary care sentinel network, whose general practicescover a population of over 4 000 000 patients. Social prescribing data will be extracted onall recorded patients for 5 years up to 31 January 2020. The objective for the qualitative component of the study isto explore approaches to understand the contextual factors that will have influenced our quantitative findings to identify mechanisms to encourage adoption of social prescribing in primary care while improving data quality. Itwill comprise up to three 90–120 minute advisory group meetings for six to eight participants. Participants will be recruited based on their experience of delivering primary care within Oxfordshire and Surrey. The advisory group outputs will be analysed using framework analysis and will be used to create a survey instrument consisting of statements that surveyees, who will consist of primary care practitioners within the RCGP RSC, can agree or disagree with. ETHICS AND DISSEMINATION: All RCGP RSC data are pseudonymised at the point of data extraction. No personally identifiable data are required for this investigation. This protocol follows the Good Reporting of a Mixed Methods Study checklist. The study results will be published in a peer-reviewed journal and the dataset will be available to other researchers.
format Online
Article
Text
id pubmed-7511614
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-75116142020-10-05 Use and impact of social prescribing: a mixed-methods feasibility study protocol Jani, Anant Liyanage, Harshana Hoang, Uy Moore, Lucy Ferreira, Filipa Yonova, Ivelina Tzortziou Brown, Victoria de Lusignan, Simon BMJ Open General practice / Family practice INTRODUCTION: Social prescribing aims to address social determinants of health, which account for 80%–90% of health outcomes, but the evidence base behind it is limited due to a lack of data linkingsocial prescribing activity and outcomes. METHODS AND ANALYSIS: The objective of the quantitative component of this feasibility studyisto identify the characteristics of individuals who receive social prescriptions and describe the use and estimate the impact of social prescribing; the latter will be done on a homeless subgroup. We will use the Oxford Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) primary care sentinel network, whose general practicescover a population of over 4 000 000 patients. Social prescribing data will be extracted onall recorded patients for 5 years up to 31 January 2020. The objective for the qualitative component of the study isto explore approaches to understand the contextual factors that will have influenced our quantitative findings to identify mechanisms to encourage adoption of social prescribing in primary care while improving data quality. Itwill comprise up to three 90–120 minute advisory group meetings for six to eight participants. Participants will be recruited based on their experience of delivering primary care within Oxfordshire and Surrey. The advisory group outputs will be analysed using framework analysis and will be used to create a survey instrument consisting of statements that surveyees, who will consist of primary care practitioners within the RCGP RSC, can agree or disagree with. ETHICS AND DISSEMINATION: All RCGP RSC data are pseudonymised at the point of data extraction. No personally identifiable data are required for this investigation. This protocol follows the Good Reporting of a Mixed Methods Study checklist. The study results will be published in a peer-reviewed journal and the dataset will be available to other researchers. BMJ Publishing Group 2020-09-18 /pmc/articles/PMC7511614/ /pubmed/32948564 http://dx.doi.org/10.1136/bmjopen-2020-037681 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle General practice / Family practice
Jani, Anant
Liyanage, Harshana
Hoang, Uy
Moore, Lucy
Ferreira, Filipa
Yonova, Ivelina
Tzortziou Brown, Victoria
de Lusignan, Simon
Use and impact of social prescribing: a mixed-methods feasibility study protocol
title Use and impact of social prescribing: a mixed-methods feasibility study protocol
title_full Use and impact of social prescribing: a mixed-methods feasibility study protocol
title_fullStr Use and impact of social prescribing: a mixed-methods feasibility study protocol
title_full_unstemmed Use and impact of social prescribing: a mixed-methods feasibility study protocol
title_short Use and impact of social prescribing: a mixed-methods feasibility study protocol
title_sort use and impact of social prescribing: a mixed-methods feasibility study protocol
topic General practice / Family practice
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511614/
https://www.ncbi.nlm.nih.gov/pubmed/32948564
http://dx.doi.org/10.1136/bmjopen-2020-037681
work_keys_str_mv AT janianant useandimpactofsocialprescribingamixedmethodsfeasibilitystudyprotocol
AT liyanageharshana useandimpactofsocialprescribingamixedmethodsfeasibilitystudyprotocol
AT hoanguy useandimpactofsocialprescribingamixedmethodsfeasibilitystudyprotocol
AT moorelucy useandimpactofsocialprescribingamixedmethodsfeasibilitystudyprotocol
AT ferreirafilipa useandimpactofsocialprescribingamixedmethodsfeasibilitystudyprotocol
AT yonovaivelina useandimpactofsocialprescribingamixedmethodsfeasibilitystudyprotocol
AT tzortzioubrownvictoria useandimpactofsocialprescribingamixedmethodsfeasibilitystudyprotocol
AT delusignansimon useandimpactofsocialprescribingamixedmethodsfeasibilitystudyprotocol